SEC Form 4 · accession 0001140361-26-033637
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mayukh Sukhatme
Officer — President & CIO · Director
Period of report
Aug 14, 2026
Accepted (ET)
Aug 18, 2026 · 9:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 14, 2026 | M | 243,177 | $3.85 | A | 18,873,916 | D | |
| Common SharesF1 | Aug 14, 2026 | S | 243,177 | $36.23 | D | 18,630,739 | D | |
| Common Shares | Aug 17, 2026 | M | 284,707 | $3.85 | A | 18,915,446 | D | |
| Common SharesF2 | Aug 17, 2026 | S | 284,707 | $36.25 | D | 18,630,739 | D | |
| Common Shares | Aug 18, 2026 | M | 105,141 | $3.85 | A | 18,735,880 | D | |
| Common SharesF3 | Aug 18, 2026 | S | 105,141 | $36.59 | D | 18,630,739 | D | |
| Common Shares | Aug 18, 2026 | M | 31,801 | $3.85 | A | 18,662,540 | D | |
| Common SharesF4 | Aug 18, 2026 | S | 31,801 | $37.18 | D | 18,630,739 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common SharesF5 | $3.85 | Aug 14, 2026 | M | 243,177 | D | — | Apr 19, 2032 | Common Shares | 243,177 | 13,981,186 | D |
| Common SharesF5 | $3.85 | Aug 17, 2026 | M | 284,707 | D | — | Apr 19, 2032 | Common Shares | 284,707 | 13,696,479 | D |
| Common SharesF5 | $3.85 | Aug 18, 2026 | M | 136,942 | D | — | Apr 19, 2032 | Common Shares | 136,942 | 13,559,537 | D |
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F5Award of stock options to purchase Common Shares that is fully vested.
Remarks
Exhibit 24 - Power of Attorney